192 related articles for article (PubMed ID: 38162661)
1. Exploring the gut mycobiome: differential composition and clinical associations in hypertension, chronic kidney disease, and their comorbidity.
Qiu J; Zhao L; Cheng Y; Chen Q; Xu Y; Lu Y; Gao J; Lei W; Yan C; Ling Z; Wu S
Front Immunol; 2023; 14():1317809. PubMed ID: 38162661
[TBL] [Abstract][Full Text] [Related]
2. Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains.
Zou Y; Ge A; Lydia B; Huang C; Wang Q; Yu Y
Front Immunol; 2022; 13():1089295. PubMed ID: 36643913
[TBL] [Abstract][Full Text] [Related]
3. Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated With Immunological Profiles.
Hu J; Wei S; Gu Y; Wang Y; Feng Y; Sheng J; Hu L; Gu C; Jiang P; Tian Y; Guo W; Lv L; Liu F; Zou Y; Yan F; Feng N
Front Immunol; 2022; 13():843695. PubMed ID: 35784313
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension.
Chen BY; Lin WZ; Li YL; Bi C; Du LJ; Liu Y; Zhou LJ; Liu T; Xu S; Shi CJ; Zhu H; Wang YL; Sun JY; Liu Y; Zhang WC; Zhang Z; Zhang HL; Zhu YQ; Duan SZ
Microbiol Spectr; 2023 Feb; 11(1):e0195622. PubMed ID: 36475759
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
Yadav M; Ali S; Shrode RL; Shahi SK; Jensen SN; Hoang J; Cassidy S; Olalde H; Guseva N; Paullus M; Cherwin C; Wang K; Cho T; Kamholz J; Mangalam AK
PLoS One; 2022; 17(4):e0264556. PubMed ID: 35472144
[TBL] [Abstract][Full Text] [Related]
6. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
7. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
[TBL] [Abstract][Full Text] [Related]
8. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
9. Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes.
Ren Y; Chen L; Guo R; Ma S; Li S; Zhang Y; Jiang H; Shi H; Zhang P
J Transl Med; 2024 Feb; 22(1):202. PubMed ID: 38403655
[TBL] [Abstract][Full Text] [Related]
10. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
12. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
13. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
14. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
[TBL] [Abstract][Full Text] [Related]
15. Population-Level Configurations of Gut Mycobiome Across 6 Ethnicities in Urban and Rural China.
Sun Y; Zuo T; Cheung CP; Gu W; Wan Y; Zhang F; Chen N; Zhan H; Yeoh YK; Niu J; Du Y; Zhang F; Wen Y; Yu J; Sung JJY; Chan PKS; Chan FKL; Wang K; Ng SC; Miao Y
Gastroenterology; 2021 Jan; 160(1):272-286.e11. PubMed ID: 32956679
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.
Yang X; Cai S; Gong J; Zhang J; Lian M; Chen R; Zhou L; Bai P; Liu B; Zhuang M; Tan H; Xu J; Li M
Int Urol Nephrol; 2024 May; 56(5):1751-1762. PubMed ID: 38085410
[TBL] [Abstract][Full Text] [Related]
17. Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Pietrzak B; Schmidt M; Galus Ł; Mackiewicz J; Mackiewicz A; Kozlowski P; Philips A
Cancer Immunol Res; 2024 Apr; 12(4):427-439. PubMed ID: 38315788
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
Yadav A; Yadav R; Sharma V; Dutta U
Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
[TBL] [Abstract][Full Text] [Related]
19. Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.
Liu Q; Zhang W; Pei Y; Tao H; Ma J; Li R; Zhang F; Wang L; Shen L; Liu Y; Jia X; Hu Y
BMC Med; 2023 Oct; 21(1):409. PubMed ID: 37904139
[TBL] [Abstract][Full Text] [Related]
20. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development.
Li J; Yang X; Zhou X; Cai J
Antioxid Redox Signal; 2021 Apr; 34(10):811-830. PubMed ID: 32316741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
